Two group IV precursors, titanium(IV) neo-pentoxide, [Ti(m-ONep) (ONep) 3 ] 2 (1, where ONep = OCH 2 C(CH 3 ) 3 ), and zirconium(IV) neo-pentoxide, [Zr(m-ONep)(ONep) 3 ] 2 (2), were found to possess relatively high volatility at low temperatures. These compounds were therefore investigated as metal±organic CVD (MOCVD) precursors using a lamp-heated cold-wall CVD reactor by direct vaporization without a carrier gas. The ONep derivatives proved to be competitive precursors for the production of thin films of the appropriate MO 2 (M = Ti or Zr) materials in comparison to other metallo-organic precursors. Compound 1 was found to vaporize at 120 C with a deposition rate of~0.350 mm/min onto a substrate at 330 C forming the anatase phase with <1 % residual C found in the final film. Compound 2 was found to vaporize at 160 C and deposited a crystalline material at 300 C with <1 % residual C found in the final film. A comparison with standard alkoxide and b-diketonates is presented where appropriate.
Thin sacrificial films are used as cap layer in the back-end semiconductor processing for protecting the bulk porous inter-layer low-k dielectric during the CMP process. The existing optical measurement techniques struggle to separate these thin films from the bulk low-k due to very similar optical coefficients. Glancing angle x-ray reflectivity is well suited for separation of thin sacrificial film and bulk dielectric film as x-ray reflectivity depends strongly on changes in electron densities for two materials. This paper discusses the x-ray reflectivity technique and its applications for measurement of low-k stack and sacrificial oxide post CMP.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.